ORIGINAL RESEARCH article

Front. Oncol., 03 February 2025

Sec. Gastrointestinal Cancers: Colorectal Cancer

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1535271

Application of cellular microstructural diffusion MRI (cell size imaging) in rectal lesions: a preliminary study

  • 1. Department of Magnetic Resonance Imaging (MRI), The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

  • 2. Clinical and Technical Support, Philips Healthcare, Beijing, China

  • 3. Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Abstract

Objectives:

To explore the value of cellular microstructural mapping by IMPULSED (imaging microstructural parameters using limited spectrally edited diffusion) method in evaluating the histological type and prognostic factors of rectal lesions.

Materials and methods:

Sixty-six patients with rectal lesions were enrolled in this study. All subjects underwent MRI scans including conventional diffusion weighted imaging (DWI) and the IMPULSED MRI scans of oscillating gradient spin-echo (OGSE) and pulse gradient spin-echo (PGSE) sequences. Parameters including mean cell diameter (dmean), intracellular fraction (vin), extracellular diffusivity (dex), cellularity, and apparent diffusion coefficient (ADC) values (ADCPGSE, ADC17Hz, ADC33Hz, and ADC of conventional DWI) were measured in different histopathologic types, grades, stages, and structure invasion statuses. The receiver operating characteristic (ROC) curve analysis was used to evaluate diagnostic power. The sensitivity, specificity, and the corresponding area under the curves (AUCs) were calculated.

Results:

Our preliminary results illustrated that malignant lesion showed higher vin and cellularity ([0.2867 ± 0.0697] vs. [0.1856 ± 0.1011], [2.3508 ± 0.6055] vs. [1.2716 ± 0.4574], all P<0.05), lower dex and ADC values (ADCPGSE, ADC17Hz, and ADC of conventional DWI) compared to benign lesion ([2.1637 ± 0.3303 μm2/ms] vs. [2.5595 ± 0.5085 μm2/ms], [0.9238 (0.7959, 1.0741) ×10-3 mm2/s] vs. [1.3373 ± 0.3902×10-3 mm2/s], [1.3204 ± 0.2342×10-3 mm2/s] vs. [1.8029 ± 0.3119×10-3 mm2/s], [0.7400 (0.6750, 0.8375) ×10-3 mm2/s] vs. [1.0550 ± 1.1191×10-3 mm2/s], all P<0.05), while no significant difference was seen for dmean. Vin and cellularity of rectal common adenocarcinoma (AC) were significantly higher than those of rectal mucinous adenocarcinoma (MC) ([0.2994 ± 0.0626] vs. [0.2028 ± 0.0571], [2.4579 ± 0.5553] vs. [1.6412 ± 0.4347], all P<0.05), while dex and ADC values (ADCPGSE, ADC17Hz, ADC33Hz, and ADC of conventional DWI) were lower in AC ([2.1189 ± 0.3187 μm2/ms] vs. [2.4609 ± 0.2534 μm2/ms], [0.8996 ± 0.1583×10-3 mm2/s] vs. [1.2072 ± 0.2326×10-3 mm2/s], [1.2714 ± 0.1916×10-3 mm2/s] vs. [1.6451 ± 0.2420×10-3 mm2/s], [1.8963 (1.6481, 2.1138) ×10-3 mm2/s] vs. [2.3104 ± 0.3851×10-3 mm2/s], [0.7341 ± 0.8872×10-3 mm2/s] vs. [1.1410 ± 0.1840×10-3 mm2/s], all P<0.05). In AC group, the dmean had significant difference between negative and positive tumor budding (TB) ([13.2590 ± 1.3255 μm] vs. [14.3014 ± 1.1830 μm], P<0.05). No significant difference of dmean, vin, dex, cellularity or ADC values was observed in AC with different grade, T stage, N stage, perineural and lymphovascular invasion (all P>0.05). The ROC curves showed that the area under the curves (AUCs) of vin, dex, cellularity, and ADC values (ADCPGSE, ADC17Hz, and ADC of conventional DWI) for distinguishing malignant and benign lesion were 0.803, 0.757, 0.948, 0.807, 0.908 and 0.905, respectively. The AUCs of vin, dex, cellularity, and ADC values (ADCPGSE, ADC17Hz, ADC33Hz, and ADC of conventional DWI) in distinguishing AC from MC were 0.887, 0.802, 0.906, 0.896, 0.896, 0.781 and 0.991, respectively. The AUC of the dmean for evaluating TB status was 0.726. The AUC of ADC from conventional DWI for evaluating WHO grade was 0.739.

Conclusion:

Cellular microstructural mapping by the IMPULSED method has great potential in preoperative evaluation of rectal lesions. It could be helpful in differentiating malignant and benign lesions, distinguishing AC from MC, and in predicting the TB status.

1 Introduction

Colorectal cancer (CRC) is a common malignant tumor in the digestive system, which is the third most common cancer and the second most common cause of cancer-related death in global (1). About 30% occur in the rectum (2), and 90% are classified as adenocarcinoma (AC). Many factors affect the choice of treatment methods and prognosis of patients, such as pathological types, tumor grade, T stage, and N stage. For example, rectal mucinous adenocarcinoma (MC) is a common subtype of rectal adenocarcinomas, which is not sensitive to neoadjuvant chemoradiotherapy and has a poor prognosis. In addition to malignant tumors, benign lesions could also occur in the rectum, such as rectal adenomas, inflammatory lesions, etc. However, preoperative classification of rectal lesions remains challenging. Magnetic resonance imaging (MRI) has become the preferred imaging method for diagnosis of rectal lesions due to its excellent soft tissue resolution. However, few evidences are available about the application of MRI in preoperative evaluation of rectal benign lesions.

The conventional diffusion-weighted magnetic resonance imaging (dMRI) along with the derived apparent diffusion coefficient (ADC) has shown important diagnostic value in rectal lesions (3–6). Nevertheless, its performance in rectal cancer subtype analyses and the evaluation of prognostic factors is limited. One of the key reasons may lie in that ADC is a general measurement of restricted diffusion rate that cannot pinpoint the underlying pathology. Micro cellular structures including cell size, cell density, and intra- or extra-cellular volume fractions could change ADC. Recent advances in diffusion MRI for microstructural modeling provide the opportunity to characterize cancer pathology in vivo (7). Among them, the IMPULSED (imaging microstructural parameters using limited spectrally edited diffusion) method developed by Jiang etc. has been used in the study of multiple systemic diseases in patients with breast, prostate cancer, and brain tumor (8–11). However, the application value of IMPULSED MRI in evaluating pathological features of rectal lesions remains unclear.

The current study aims to explore the efficacy of the IMPULSED MRI for microstructural mapping in rectal lesions, and further to evaluate whether the obtained tumor microstructural properties could be used to distinguish prognostic factors in rectal cancer.

2 Materials and methods

2.1 Study participants

This preoperative study included 118 patients who were diagnosed with rectal lesions between April 2023 and September 2023 at our hospital. The inclusion criteria were as follows: (1) patients suspected of rectal lesions; (2) patients without surgery, chemoradiotherapy or other related treatments before the MRI examination; (3) pathological diagnosis could be obtained within two weeks after the MRI examination; The exclusion criteria were as follows: (1) patients without pathological diagnosis (n=11); (2) patients received neoadjuvant therapy (n=34); (3) poor image quality (n=5); (4) patients with rectal lymphomas, neuroendocrine tumor and other rare tumors (n=1); and (5) patients with a history of other malignant tumors (n=1). Finally, 66 patients were enrolled in this study cohort (Figure 1).

Figure 1

2.2 Magnetic resonance imaging protocols

MRI was performed on a 3T scanner (Ingenia Elition, Philips Healthcare, Best, the Netherlands) with a high-performance gradient system (maximum gradient = 45 mT/m per axis, maximum slew rate = 220 mT/m) and a 24-channel abdominal coil. Patients need to empty the rectum before MRI examination. The oscillating gradient spin-echo (OGSE) sequence with trapezoid-cosine gradients and the pulse gradient spin-echo (PGSE) diffusion weighted sequence were implemented with 2D echo-planar imaging acquisition. Table 1 shows detailed diffusion encoding parameters for PGSE and OGSE scans. Routine pre-contrast MRI scans included T1-weighted imaging, fat-suppressed T2-weighted imaging, and conventional diffusion-weighted imaging (DWI). The post-contrast T1-weighted images were acquired for anatomical reference. The patients did not require too much special preparations, and the whole scan took less than half an hour.

Table 1

PGSEOGSE17HzOGSE33Hz
TR (ms)400040004000
TE (ms)145145145
Field of views (mm2)192×192192×192192×192
Voxel size (mm3)2.53×2.58×52.53×2.58×52.53×2.58×5
Flip angle (°)909090
Matrix size76×7476×7476×74
Reconstructed voxel size (mm2)1.2×1.2×5M1.2×1.2×51.2×1.2×5
Cycle/12
f (Hz)/1733
Effective td (ms)26.7157.5
b-value (s/mm2)0/250/500/750/1000/1400/18000/250/500/750/10000/100/200/300
Bandwidth (pixel/Hz)37.237.237.2
Scan duration4min24s4min12s2min08s

Scan parameters for the IMPULSED MRI of PGSE and OGSE sequences.

IMPULSED, imaging microstructural parameters using limited spectrally edited diffusion; MRI, magnetic resonance imaging; PGSE, pulse gradient spin-echo; OGSE, oscillating gradient spin-echo.

2.3 Image analysis and data acquisition

High-resolution T2WI was used to evaluate tumor location, tumor size, and bowel circumferential involvement. The estimation of IMPULSED parameters included mean cell diameter (dmean), intracellular fraction (vin), extracellular diffusivity (dex), and cellularity, while intracellular diffusivity (Din) was fixed at 1.58 μm2/ms to ensure fitting stability. The parameters were constrained to 4 < dmean <30 μm, 0 < vin < 1, and 0 < dex <3.5 μm2/ms based on physiologically relevant values. The fitting was performed using the least square curve fitting toolbox in MATLAB (Mathworks, Inc.). Additionally, the apparent diffusion coefficient (ADC) values were fitted according to S/S0 = exp(−b×ADC) using a log-linear fitting with all b values for PGSE/OGSE.

In patients with rectal lesion, the regions-of-interest (ROIs) were manually delineated on the slice with the largest scale of the lesion based on diffusion-weighted images by two experienced radiologists independently, and necrotic area or surrounding tissue was carefully excluded from the segmentation. The fitted microstructural parameters, including dmean, vin, dex, cellularity, and ADC (ADCPGSE, ADC17Hz, ADC33Hz), were calculated in a voxel-wise manner and averaged within the tumor ROIs. And the image quality was evaluated by two radiologists independently according to the artifact and noise (1 score, both strongly obvious; 2 score, both obvious; 3 score, slight artifacts and noise, but acceptable; 4 score, no artifact and slight noise; 5 score, no artifact and noise).

2.4 Pathologic evaluation

The pathological diagnosis was evaluated by a pathologist with >5 years of experience, who was blinded to the MRI diagnosis. The pathological reports included the diagnosis of benign and malignant lesions. For malignant lesions, pathological reports should contain histological types, tumor grade, pathological stage, perineural invasion (PNI), and lymphovascular invasion (LVI), and tumor budding (TB). Tumor grades were classified as low-grade and high-grade, the former included grade 1 (G1, well- differentiated, >95% gland forming) and grade 2 (G2, moderately differentiated, 50–95% gland forming), and the latter referred to grade 3 (G3, poorly differentiated, 0-49% gland forming). Pathological stage included T staging and N staging. Pathological T staging was divided into early and late stages according to the American Joint Committee on Cancer (AJCC) 8th edition. Early-stage rectal cancer included stages pT1 and pT2, which was defined as tumor confined to the muscularis propria. Late-stage rectal cancer included stages pT3 and pT4, which referred to tumor extending beyond the muscularis propria. According to the status of regional lymph node, pathological N staging was divided into two categories, including lack of regional lymph node metastases (pN0) and regional lymph node metastasis (pN1-2). PNI, LVI and TB statuses were classified into positive and negative groups.

2.5 Statistical analysis

SPSS 27.0 software (IBM Corp., Armonk, NY, USA) and MedCalc (MedCalc Software, Mariakerke, Belgium) were used for the statistical analyses. GraphPad Prism software (version 10.1.2, GraphPad Software, San Diego, CA, USA) was used to make diagrams. The Shapiro–Wilk test (n ≤ 50) and Kolmogorov-Smirnov test (n>50) were used to determine normal or skewed data distribution for all continuous variables. The normally distributed data were expressed as mean ± standard deviation (SD). The non-normally distributed data were expressed as median (1st quartile, 3rd quartile). The two-independent samples t-test or the Mann–Whitney U test were used to compare dmean, vin, dex, cellularity and ADC parameters between histological types (malignant lesion vs. benign lesion; AC vs. MC), tumor grades (low grade vs. high grade), pT stages (pT1-2 vs. pT3-4), pN stages (pN0 vs. pN1-2), PNI (negative vs. positive), LVI (negative vs. positive), and TB (negative vs. positive). For parameters with significant differences, the receiver operating characteristic (ROC) curve analysis was used to evaluate diagnostic power. The sensitivity, specificity, and area under the curve (AUC) were calculated, and the cut-off value was also obtained using the Youden index (Youden’s index = sensitivity + specificity - 1). The intraclass correlation coefficient (ICC) and Kappa test were used to evaluate the agreement of measured parameters between the two radiologists. ICC values of greater than 0.75 and Kappa coefficient of greater than 0.80 were considered to good agreement. A probability of P values <0.05 was considered statistically significant.

3 Results

3.1 Patient characteristics

A total of 66 patients (61 in the malignant group and 5 in the benign group) were enrolled in this study. In the malignant group, 53 were classified as AC and 8 were classified as MC according to the results of postoperative pathology. Basic demographic and clinical information of the patients were summarized in Table 2.

Table 2

CharacteristicsNumber of patients
Gender
 Male41
 Femal25
Age
 Mean age, years59 ± 9.322
 Age range, years37-78
Pathological type
 benign lesions5
 MC8
 AC53
WHO grade (AC)
 Low-grade39
 High-grade14
T stage (AC)
 pT1-219
 pT3-434
N stage (AC)
 pN023
 pN1-230
PNI (AC)
 Negative27
 Positive26
LVI (AC)
 Negative29
 Positive24
TB (AC)
 Negative24
 Positive29

Clinical and pathologic characteristics of the study patients.

MC, mucinous adenocarcinoma; AC, adenocarcinoma; PNI, perineural invasion; LVI, lymphovascular invasion; TB, tumor budding.

3.2 Agreement of measured parameters between the two radiologists

There were good agreements between two observers. The ICC were 0.879 (95% CI 0.810–0.924) for dmean; 0.909 (95% CI, 0.849–0.945) for vin; 0.889 (95%CI, 0.812–0.933) for dex; 0.863 (95% CI,0.785–0.914) for cellularity; 0.914 (95% CI, 0.863–0.947) for ADCPGSE, 0.929 (95% CI, 0.887–0.956) for ADC17Hz, 0.924 (95% CI, 0.879–0.953) for ADC33Hz, and 0.974 (95% CI, 0.958-0.984) for ADC of conventional DWI, respectively. In addition, it showed high consistency in the evaluation of image quality (κ = 0.813).

3.3 Microstructural features and ADCs of different pathological types in rectal lesion

Compared to benign lesion, the vin and cellularity were significantly higher, the dex and ADC values (ADCPGSE, ADC17Hz, and ADC of conventional DWI) were significantly lower in malignant lesion (all P<0.05) (Table 3, Figure 2). There was no significant difference about dmean between the two groups. Vin and cellularity of rectal common adenocarcinoma (AC) were significantly higher than those of rectal mucinous adenocarcinoma (MC), while dex and ADC values (ADCPGSE, ADC17Hz, ADC33Hz, and ADC of conventional DWI) were lower in AC (all P<0.05) (Table 4, Figure 3).

Table 3

Pathologic typedmean (μm)vindex (μm2/ms)cellularity
(×10-2)
ADCPGSE
(×10-3 mm2/s)
ADC17Hz
(×10-3 mm2/s)
ADC33Hz
(×10-3 mm2/s)
ADC
(×10-3 mm2/s)
Malignant lesion (n=61)13.8106 ± 1.32890.2867 ± 0.06972.1637 ± 0.33032.3508 ± 0.60550.9238
(0.7959, 1.0741)
1.3204 ± 0.23421.9376 (1.6861, 2.2621)0.7400
(0.6750, 0.8375)
Benign lesion (n=5)15.7237 ± 3.40890.1856 ± 0.10112.5595 ± 0.50851.2716 ± 0.45741.3373 ± 0.39021.8029 ± 0.31192.7902 ± 1.18751.0550 ± 1.1191
P value0.27880.00370.01610.00020.02080.00010.09540.003

Comparison of dmean, vin, dex, cellularity and ADC values (ADCPGSE, ADC17Hz, ADC33Hz, and ADC of conventional DWI) between malignant and benign lesions.

ADC, apparent diffusion coefficient.

Figure 2

Table 4

Malignant lesiondmean (μm)vindex (μm2/ms)cellularity
(×10-2)
ADCPGSE
(×10-3 mm2/s)
ADC17Hz
(×10-3 mm2/s)
ADC33Hz
(×10-3 mm2/s)
ADC
(×10-3 mm2/s)
AC (n=53)13.8177 ± 1.34310.2994 ± 0.06262.1189 ± 0.31872.4579 ± 0.55530.8996 ± 0.15831.2714 ± 0.19161.8963 (1.6481, 2.1138)0.7341 ± 0.8872
MC (n=8)13.7640 ± 1.31700.2028 ± 0.05712.4609 ± 0.25341.6412 ± 0.43471.2072 ± 0.23261.6451 ± 0.24202.3104 ± 0.38511.1410 ± 0.1840
P value0.91630.00010.00530.00020.00000.00000.0110.0000

Comparison of dmean, vin, dex, cellularity and ADC values (ADCPGSE, ADC17Hz, ADC33Hz, and ADC of conventional DWI) between AC and MC.

ADC, apparent diffusion coefficient; AC, adenocarcinoma; MC, mucinous adenocarcinoma.

Figure 3

3.4 Comparison of microstructural features and ADCs in different subtype groups of rectal adenocarcinomas

In AC group, the dmean was higher in positive tumor budding (TB) group (P<0.05), and ADC of conventional DWI was higher in low-grade group (P<0.05) (Table 5, Figure 4). No significant difference of dmean, vin, dex, cellularity or other ADC values (ADCPGSE, ADC17Hz, ADC33Hz, and ADC of conventional DWI) was observed in other groups (all P>0.05).

Table 5

Groupsdmean (μm)vindex (μm2/ms)cellularity
(×10-2)
ADCPGSE
(×10-3 mm2/s)
ADC17Hz
(×10-3 mm2/s)
ADC33Hz
(×10-3 mm2/s)
ADC
(×10-3 mm2/s)
WHO grade
Low-grade (n=39)13.7929 ± 1.14110.2958 ± 0.06112.0936 ± 0.30962.4383 ± 0.54150.9023 ± 0.15261.2703 ± 0.19321.8963 (1.6249, 2.0579)0.7518 ± 0.0848
High-grade (n=14)13.8868 ± 1.84470.3096 ± 0.06802.1893 ± 0.34492.5124 ± 0.61000.8518 (0.7959, 0.9687)1.2742 ± 0.19421.9381 (1.7199, 2.2843)0.6850 ± 0.0833
P value0.86040.48490.34040.67300.58600.94930.26720.0173
T stage
pT1-2 (n=19)13.8886 ± 0.94100.2940 ± 0.06962.1608 ± 0.32822.4074 ± 0.63610.9357 ± 0.17411.2996 ± 0.24071.9905 ± 0.26720.7600 ± 0.0986
pT3-4 (n=34)13.7781 ± 1.53460.3025 ± 0.05932.0464 (1.9031, 2.2253)2.4861 ± 0.51280.8794 ± 0.14751.2556 ± 0.15981.8315 (1.5995, 2.0734)0.7197 ± 0.0806
P value0.77691.53460.22090.62550.21830.42710.12820.1136
N stage
pN0 (n=23)13.4390 ± 1.23800.2904 ± 0.07412.1901 ± 0.35492.4182 ± 0.62550.9360 ± 0.20061.3038 ± 0.22411.9891 (1.6492, 2.2950)0.7450 ± 0.09189
pN1-2 (n=30)14.1080 ± 1.36780.3063 ± 0.05242.0643 ± 0.28192.4883 ± 0.50400.8717 ± 0.11201.2864 (1.1547, 1.3711)1.8416 (1.6205, 1.6205)0.7258 ± 0.0869
P value0.07190.36540.15640.65340.17710.54180.26590.4410
PNI
Negative (n=27)13.8252 ± 1.24480.3051 ± 0.06992.0857 ± 0.28462.4928 ± 0.58230.8832 ± 0.17151.2609 ± 0.18641.8043 (1.6249, 2.1076)0.7343 ± 0.0876
Positive (n=26)13.8099 ± 1.46310.2935 ± 0.05482.1534 ± 0.35302.4216 ± 0.53490.9167 ± 0.14461.2823 ± 0.20001.9218 (1.7662, 2.1360)0.7340 ± 0.0916
P value0.96750.50770.44470.64540.44610.68800.28570.9929
LVI
Negative (n=29)13.5197 ± 1.23060.3013 ± 0.07022.1381 ± 0.37202.5024 ± 0.57600.9117 ± 0.18711.2702 ± 0.22761.9173 (1.6634, 2.2635)0.7379 ± 0.9788
Positive (n=24)14.1777 ± 1.40980.2972 ± 0.05332.0957 ± 0.24542.4041 ± 0.53640.8849 ± 0.11671.2727 ± 0.14111.8416 (1.6123, 1.9918)0.7200 (0.6600, 0.7863)
P value0.07560.80800.62150.52670.52710.96140.24550.7476
TB
Negative (n=24)13.2590 ± 1.32550.2873 ± 0.06692.0849 ± 0.34702.4609 ± 0.60310.9211 ± 0.17291.2645 ± 0.21531.9473 ± 0.37170.7423 ± 0.0959
Positive (n=29)14.2800 ± 1.19080.3095 ± 0.05812.1470 ± 0.29652.4554 ± 0.52340.8818 ± 0.14571.2770 ± 0.17331.8963 (1.6481, 2.1138)0.7274 ± 0.0834
P value0.00480.20270.48510.97170.37300.81570.98570.5485

The comparison of dmean, vin, dex, cellularity and ADC values (ADCPGSE, ADC17Hz, ADC33Hz, and ADC of conventional DWI) in different groups of AC.

ADC, apparent diffusion coefficient; AC, adenocarcinoma; PNI, perineural invasion; LVI, lymphovascular invasion; TB, tumor budding.

Figure 4

3.5 Comparison of ROC curves

The area under the curves (AUCs) for distinguishing malignant from benign lesions using the vin, dex, cellularity, and ADC values (ADCPGSE, ADC17Hz, and ADC of conventional DWI) were 0.803, 0.757, 0.948, 0.807, 0.908 and 0.905,respectively (Figures 5A, D). The AUCs of vin, dex, cellularity, and ADC values (ADCPGSE, ADC17Hz, ADC33Hz, and ADC of conventional DWI) for distinguishing AC from MC were 0.887, 0.802, 0.906, 0.896, 0.896, 0.781 and 0.991, respectively (Figures 5B, E). The AUC of the dmean for evaluating TB status was 0.726 (Figure 5C). The AUC of ADC from conventional DWI for evaluating WHO grade was 0.739 (Figure 5F). The diagnostic performance and optimal diagnostic cut-off values were shown in Table 6.

Figure 5

Table 6

CategorySensitivitySpecificityAUC (95%CI)CutoffP value
Malignant lesion vs. Benign lesion
vin85.25%80.00%0.803 (0.687-0.891)0.21680.0392
dex80.33%80.00%0.757 (0.636-0.854)2.4633 μm2/ms0.1292
cellularity86.89%100.00%0.948 (0.863-0.987)1.8314×10-2<0.0001
ADCPGSE90.16%80.00%0.807 (0.691-0.893)1.2017 (×10-3 mm2/s)0.0473
ADC17Hz93.44%80.00%0.908 (0.811-0.965)1.6314 (×10-3 mm2/s)<0.0001
ADC81.97%100%0.905 (0.807-0.963)0.90 (×10-3 mm2/s)<0.0001
AC vs. MC
vin66.04%100.00%0.887 (0.780-0.954)0.2720<0.0001
dex75.47%87.50%0.802 (0.680-0.893)2.3054 μm2/ms0.0006
cellularity71.70%100.00%0.906 (0.803-0.966)2.081×10-2<0.0001
ADCPGSE77.36%100.00%0.896 (0.791-0.960)0.9786 (×10-3 mm2/s)<0.0001
ADC17Hz90.57%87.50%0.896 (0.791-0.960)1.5144 (×10-3 mm2/s)<0.0001
ADC33Hz66.04%87.50%0.781 (0.656-0.876)1.9922 (×10-3 mm2/s)0.0002
ADC92.45%100%0.991 (0.924-1.000)0.86 (×10-3 mm2/s)<0.0001
Low-grade vs. High-grade
ADC71.43%79.49%0.739 (0.600-0.850)0.68 (×10-3 mm2/s)0.007
TB (+) vs. (-)
dmean62.07%79.17%0.726 (0.586-0.839)14.0769 μm0.002

Diagnostic performance of dmean, vin, dex, cellularity and ADC values (ADCPGSE, ADC17Hz, ADC33Hz, and ADC of conventional DWI) between different groups.

ADC, apparent diffusion coefficient; AC, adenocarcinoma; MC, mucinous adenocarcinoma; TB, tumor budding.

4 Discussion

CRC showed an upward trend and have been one of the leading cancer types in China (12). Preoperative diagnosis of rectal cancer is extremely important for the prognosis of patients, especially the early diagnosis of benign and malignant rectal lesions. However, conventional MRI was unable to differentiate adenomas from adenocarcinomas demonstrated a potential risk for overstaging and consequently overtreatment (13). Jia et al. found that IVIM-DWI could predict rectal adenomas with canceration in a previous study (4), and the ADC value was significantly lower in the cancerous group than in the adenoma group. The recently developed td-dMRI technique has shown unique advantages in various diseases. A study by Lima et al. demonstrated that significantly lower ADC values were observed in malignant compared with benign head and neck tumors scanned using both OGSE and PGSE sequences (14). Ejima F et al. found that ADCOGSE/ADCPGSE was significantly and strongly correlated with histological grade, FIGO stage, and prognostic risk classification in uterine endometrial cancer (15). In the present study, we investigated whether the ADC values derived from OGSE and PGSE sequences and the microstructural features quantified by the IMPULSED method could be helpful for the diagnosis of rectal lesion. The scan process went smoothly for all patients, and had no additional burden on patients. Our preliminary results illustrated that the vin, dex, cellularity and ADC values can be used to differentiate malignant and benign lesions. In our study, the vin and cellularity in malignant lesion were significantly higher, the dex and ADC values were significantly lower. The changes of ADC were in accordance with the reported literature. This may be related to the increase in the volume and nuclear cytoplasmic ratio of cancer cells, resulting the limitation of dispersion of intracellular and extracellular water molecules.

MC is a specific rectal cancer subtype, and it is defined by the World Health Organization (WHO) as an adenocarcinoma in which at least 50% of the extracellular space is occupied by mucin. In large population-based studies, the MC accounts for 10–15% of rectal cancer (16). MC is more prone to local recurrence (17) and metastasizes to lymph nodes (18). Therefore, it is important to differentiate MC from AC. However, distinguishing MC from AC by the subjective judgment of radiologists is difficult. Several new MRI techniques have been used to evaluate the pathological features of rectal cancer. Some studies found that the APT SI, T1 relaxation time, and ADC value of MC were significantly higher than those of AC (19, 20). Zhang et al. explored the value of T2 mapping and DWI in MC, and the results showed that patients with MC had higher T2 and ADC values than non-MC (3). Diffusion kurtosis imaging (DKI) was considered as a more valuable imaging biomarker than conventional DWI for differentiating MC from AC, and the AUCs of MK, MD and ADC for distinguishing MC from AC were 0.97, 0.95 and 0.88 (21). In our study cohort, the microstructural index of vin and cellularity of rectal AC were significantly higher than MC, while dex and ADC values were lower in AC. We considered that these results were consistent with the component of MC, owing to its low cellular density and high amounts of water molecules, especially extracellular water. The AUCs for distinguishing AC from MC using vin, dex, cellularity, ADCPESE, ADC17Hz, ADC33Hz and ADC of conventional DWI were 0.887, 0.802, 0.906, 0.896, 0.896, 0.781 and 0.905, indicating high sensitivity and specificity.

The histological grade, tumor stage and lymph node metastasis are important factors in the selection of treatment plans and prognostic predictions for patients with rectal cancer. Some studies found that the ADC value by conventional DWI was not effective in determining T stages, N stages, or WHO grades of rectal cancer (5, 22). However, Ge et al. found that the mean T2 and ADC values for metastatic lymph nodes were significantly lower than for benign lymph nodes in patients with non-mucinous rectal adenocarcinoma (23). Chen et al. found that the APT SI was significantly higher in rectal tumors with high grade, T3 stage, and lymph node involvement (24). In our study, ADC value of conventional DWI was higher in low-grade group, and the AUC for evaluating WHO grade was 0.739. No significant differences in dmean, vin, dex, cellularity, and other ADC values was observed in the subgroups of different histological grade, T and N stages, which may because the differences in tumor microenvironments were insufficient to cause significant changes or due to the limited sample size. In addition, metastatic lymph nodes were not evaluated separately in the present study, whether parameters from td-MRI can predict lymph node status needs more relevant research.

Recently, there is an increasing interest in PNI and LVI as a potential route of tumor spread, in addition to the well-known routes of direct extension, lymphatic metastasis, and hematogenous metastasis (25, 26). PNI is defined as the biological process characterized by cancer cells invading the nerves and spreading along the nerve sheaths. Recent advances in radiomics have been used to predict PNI status in rectal cancer (27–30), which demonstrating a good predictive effect, but the results lacked generalizability. Zhang et al. investigated the value of the pre-operative amide proton transfer-weighted (APTw) MRI to assess the prognostic factors in rectal adenocarcinoma, and they found PNI positive APTw signal intensities were higher than non-PNI group (31). LVI refers to tumor cells distributed in the endothelial lumen or destroying the corresponding lymphatic or vascular walls, which is considered a gateway to local spread or distant metastasis of cancer cells. Several studies using IVIM have been shown to be useful for in detecting LVI, but the diagnostic efficiency was limited (32, 33). We attempt to explore the value of IMPULSED MRI in predicting the status of PNI and LVI. However, there was no significant differences in positive and negative groups. The preoperative prediction of PNI and LVI status is still challenging and needs further study.

TB, as a process of epithelial-mesenchymal transition in tumors, refers to the presence of scattered tumor cells or small clusters of tumor cells with poor differentiation at the invasive front of the tumor, observed under high-power microscopy. TB was a strong negative prognostic predictor of survival in rectal cancer patients after neoadjuvant therapy (34). Qu et al. found that radiomics model based on MR T2WI could provide an effective and noninvasive method for preoperative TB grading assessment in patients with rectal cancer (35). Peng et al. assessed TB in rectal cancer using multiparameter MRI radiomics, and the AUC of the combined model was 0.961 and 0.891 in the training and validation cohorts, respectively (36). In our research, the dmean showed high discriminative power in separating TB status in AC. The AUC of the dmean for evaluating TB status was 0.726, indicating the potential value of the IMPULSED method for the noninvasive microstructural feature in rectal tumor.

However, the current study has some limitations. Firstly, this study was conducted at a single center and used a single MRI system. Secondly, our sample size was not large enough, which limited the diagnostic accuracy. Thirdly, we manually drew the region of interest (ROI), which may have a certain selection bias and cannot guarantee that necrotic and cystic tissues were completely free from ROI. Larger sample sizes and multicenter study are needed in the future to confirm the clinical value.

5 Conclusion

In summary, our study demonstrated that cellular microstructural mapping by the IMPULSED method were helpful in differentiating malignant and benign rectal lesions, and distinguishing AC from MC. The dmean showed high discriminative power in predicting TB status of AC.

Statements

Data availability statement

The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.

Ethics statement

The studies involving humans were approved by Ethics Committee of the First Affiliated Hospital of Zhengzhou University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

PK: Data curation, Formal analysis, Funding acquisition, Investigation, Writing – original draft, Writing – review & editing. LL: Data curation, Software, Writing – review & editing. YL: Writing – review & editing. HQ: Writing – review & editing. KZ: Data curation, Writing – review & editing. WZ: Data curation, Writing – review & editing. JL: Writing – review & editing. YZ: Supervision, Writing – review & editing. JC: Supervision, Writing – review & editing.

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study has received funding by science and technology research plan of Henan Provincial Health Commission (Joint construction project, LHGJ20220407).

Conflict of interest

Author LL is employed by Philips Healthcare.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1

    SungHFerlayJSiegelRLLaversanneMSoerjomataramIJemalAet al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2021) 71:209–49. doi: 10.3322/caac.21660

  • 2

    SiegelRLWagleNSCercekASmithRAJemalA. Colorectal cancer statistics, 2023. CA Cancer J Clin. (2023) 73:233–54. doi: 10.3322/caac.21772

  • 3

    ZhangJGeYZhangHWangZDouWHuS. Quantitative T2 mapping to discriminate mucinous from nonmucinous adenocarcinoma in rectal cancer: comparison with diffusion-weighted imaging. Magn Reson Med Sci. (2022) 21:593–98. doi: 10.2463/mrms.mp.2021-0067

  • 4

    JiaYSongGWuRHongYDouWLiA. Intravoxel incoherent motion DWI with different mathematical models in predicting rectal adenoma with and without canceration. Eur J Radiol. (2022) 155:110496. doi: 10.1016/j.ejrad.2022.110496

  • 5

    ZhuLPanZMaQYangWShiHFuCet al. Diffusion kurtosis imaging study of rectal adenocarcinoma associated with histopathologic prognostic factors: preliminary findings. Radiology. (2017) 284:66–76. doi: 10.1148/radiol.2016160094

  • 6

    Colakoglu ErHErdenA. Mean ADC values discriminate rectal mucinous carcinomafrom rectal nonmucinous adenocarcinoma. Turk J Med Sci. (2017) 47:1520–25. doi: 10.3906/sag-1609-59

  • 7

    JiangXLiHDevanSPGoreJCXuJ. MR cell size imaging with temporal diffusion spectroscopy. Magn Reson Imaging. (2021) 77:109–23. doi: 10.1016/j.mri.2020.12.010

  • 8

    JiangXLiHXieJMcKinleyETZhaoPGoreJCet al. In vivo imaging of cancer cell size and cellularity using temporal diffusion spectroscopy. Magn Reson Med. (2017) 78:156–64. doi: 10.1002/mrm.26356

  • 9

    XuJJiangXLiHArlinghausLRMcKinleyETDevanSPet al. Magnetic resonance imaging of mean cell size in human breast tumors. Magn Reson Med. (2020) 83:2002–14. doi: 10.1002/mrm.28056

  • 10

    WuDJiangKLiHZhangZBaRZhangYet al. Time-dependent diffusion MRI for quantitative microstructural mapping of prostate cancer. Radiology. (2022) 303:578–87. doi: 10.1148/radiol.211180

  • 11

    ZhangHLiuKBaRZhangZZhangYChenYet al. Histological and molecular classifications of pediatric glioma with time-dependent diffusion MRI-based microstructural mapping. Neuro Oncol. (2023) 25:1146–56. doi: 10.1093/neuonc/noad003

  • 12

    HeSXiaCLiHCaoMYangFYanXet al. Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors. Sci China Life Sci. (2024) 67:122–31. doi: 10.1007/s11427-023-2423-1

  • 13

    WaageJELehSRoslerCPfefferFBachSPHavreRFet al. Endorectal ultrasonography, strain elastography and MRI differentiation of rectal adenomas and adenocarcinomas. Colorectal Dis. (2015) 17:124–31. doi: 10.1111/codi.12845

  • 14

    IimaMYamamotoAKataokaMYamadaYOmoriKFeiweierTet al. Time-dependent diffusion MRI to distinguish Malignant from benign head and neck tumors. J Magn Reson Imaging. (2019) 50:88–95. doi: 10.1002/jmri.26578

  • 15

    EjimaFFukukuraYKamimuraKNakajoMAyukawaTKanzakiFet al. Oscillating gradient diffusion-weighted MRI for risk stratification of uterine endometrial cancer. J Magn Reson Imaging. (2024) 60:67–77. doi: 10.1002/jmri.29106

  • 16

    KangHO’ConnellJBMaggardMASackJKoCY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. (2005) 48:1161–8. doi: 10.1007/s10350-004-0932-1

  • 17

    HugenNvan de VeldeCJBoschSLFuttererJJElferinkMAMarijnenCAet al. Modern treatment of rectal cancer closes the gap between common adenocarcinoma and mucinous carcinoma. Ann Surg Oncol. (2015) 22:2669–76. doi: 10.1245/s10434-014-4339-5

  • 18

    NozoeTAnaiHNasuSSugimachiK. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol. (2000) 75:103–7. doi: 10.1002/1096-9098(200010)75:2<103::aid-jso6>3.0.co;2-c

  • 19

    LiJGaoXDominik NickelMChengJZhuJ. Native T1 mapping for differentiating the histopathologic type, grade, and stage of rectal adenocarcinoma: a pilot study. Cancer Imaging. (2022) 22:30. doi: 10.1186/s40644-022-00461-7

  • 20

    LiJLinLGaoXLiSChengJ. Amide proton transfer weighted and intravoxel incoherent motion imaging in evaluation of prognostic factors for rectal adenocarcinoma. Front Oncol. (2021) 11:783544. doi: 10.3389/fonc.2021.783544

  • 21

    WenZChenYYangXLuBLiuYShenBet al. Application of magnetic resonance diffusion kurtosis imaging for distinguishing histopathologic subtypes and grades of rectal carcinoma. Cancer Imaging. (2019) 19:8. doi: 10.1186/s40644-019-0192-x

  • 22

    YuanYPuHChenGWChenXLLiuYSLiuHet al. Diffusion-weighted MR volume and apparent diffusion coefficient for discriminating lymph node metastases and good response after chemoradiation therapy in locally advanced rectal cancer. Eur Radiol. (2021) 31:200–11. doi: 10.1007/s00330-020-07101-3

  • 23

    GeYXHuSDWangZGuanRPZhouXYGaoQZet al. Feasibility and reproducibility of T2 mapping and DWI for identifying Malignant lymph nodes in rectal cancer. Eur Radiol. (2021) 31:3347–54. doi: 10.1007/s00330-020-07359-7

  • 24

    ChenWLiLYanZHuSFengJLiuGet al. Three-dimension amide proton transfer MRI of rectal adenocarcinoma: correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging. Eur Radiol. (2021) 31:3286–96. doi: 10.1007/s00330-020-07397-1

  • 25

    KimYIKimCWKimJHKimJRoJSLeeJLet al. Clinical implication of perineural and lymphovascular invasion in rectal cancer patients who underwent surgery after preoperative chemoradiotherapy. Dis Colon Rectum. (2022) 65:1325–34. doi: 10.1097/DCR.0000000000002219

  • 26

    SongJHYuMKangKMLeeJHKimSHNamTKet al. Significance of perineural and lymphovascular invasion in locally advanced rectal cancer treated by preoperative chemoradiotherapy and radical surgery: Can perineural invasion be an indication of adjuvant chemotherapy? Radiother Oncol. (2019) 133:125–31. doi: 10.1016/j.radonc.2019.01.002

  • 27

    YangYSQiuYJZhengGHGongHPGeYQZhangYFet al. High resolution MRI-based radiomic nomogram in predicting perineural invasion in rectal cancer. Cancer Imaging. (2021) 21:40. doi: 10.1186/s40644-021-00408-4

  • 28

    GuoYWangQGuoYZhangYFuYZhangH. Preoperative prediction of perineural invasion with multi-modality radiomics in rectal cancer. Sci Rep. (2021) 11:9429. doi: 10.1038/s41598-021-88831-2

  • 29

    LiuYSunBJZhangCLiBYuXXDuY. Preoperative prediction of perineural invasion of rectal cancer based on a magnetic resonance imaging radiomics model: A dual-center study. World J Gastroenterol. (2024) 30:2233–48. doi: 10.3748/wjg.v30.i16.2233

  • 30

    ZhangYPengJLiuJMaYShuZ. Preoperative prediction of perineural invasion status of rectal cancer based on radiomics nomogram of multiparametric magnetic resonance imaging. Front Oncol. (2022) 12:828904. doi: 10.3389/fonc.2022.828904

  • 31

    ZhangCChenJLiuYYangYXuYYouRet al. Amide proton transfer-weighted MRI for assessing rectal adenocarcinoma T-staging and perineural invasion: a prospective study. Eur Radiol. (2024). doi: 10.1007/s00330-024-11000-2

  • 32

    WongCLiuTZhangCLiMZhangHWangQet al. Preoperative detection of lymphovascular invasion in rectal cancer using intravoxel incoherent motion imaging based on radiomics. Med Phys. (2024) 51:179–91. doi: 10.1002/mp.16821

  • 33

    LiHChenGWLiuYSPuHYinLLHouNYet al. Assessment of histologic prognostic factors of resectable rectal cancer: comparison of diagnostic performance using various apparent diffusion coefficient parameters. Sci Rep. (2020) 10:11554. doi: 10.1038/s41598-020-68328-0

  • 34

    TrotsyukISparschuhHMullerAJNeumannKKruschewskiMHorstDet al. Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy. BMC Cancer. (2019) 19:1033. doi: 10.1186/s12885-019-6261-5

  • 35

    QuXZhangLJiWLinJWangG. Preoperative prediction of tumor budding in rectal cancer using multiple machine learning algorithms based on MRI T2WI radiomics. Front Oncol. (2023) 13:1267838. doi: 10.3389/fonc.2023.1267838

  • 36

    PengLWangDZhuangZChenXXueJZhuHet al. Preoperative noninvasive evaluation of tumor budding in rectal cancer using multiparameter MRI radiomics. Acad Radiol. (2024) 31:2334–45. doi: 10.1016/j.acra.2023.11.023

Summary

Keywords

rectal lesion, adenocarcinoma, magnetic resonance imaging, diffusion, microstructure

Citation

Kou P, Lin L, Li Y, Qin H, Zhang K, Zhang W, Li J, Zhang Y and Cheng J (2025) Application of cellular microstructural diffusion MRI (cell size imaging) in rectal lesions: a preliminary study. Front. Oncol. 15:1535271. doi: 10.3389/fonc.2025.1535271

Received

27 November 2024

Accepted

15 January 2025

Published

03 February 2025

Volume

15 - 2025

Edited by

Zexian Liu, Sun Yat-sen University Cancer Center (SYSUCC), China

Reviewed by

Xianchun Zeng, Guizhou Provincial People’s Hospital, China

Fubi Hu, First Affiliated Hospital of Chengdu Medical College, China

Updates

Copyright

*Correspondence: Jingliang Cheng,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics